News Daily News Spending More Won’t Necessarily Improve Acute MI Outcomes Todd Neale December 22, 2017
News Daily News Hospital Mortality for Patients With A-fib Higher in Rural Areas Todd Neale December 11, 2017
News Daily News Hospital Readmission Patterns Post-MI in China Differ Markedly From in the US Yael L. Maxwell December 07, 2017
News Daily News Burden of Readmission High in PAD Patients Following Revascularization L.A. McKeown December 04, 2017
News Daily News It’s Official: Evolocumab Gains Claim for CVD Event Reduction Michael O'Riordan December 04, 2017
News Daily News Secondary Prevention Improves Survival After STEMI Discharge but Is Widely Underprescribed L.A. McKeown December 01, 2017
News Daily News Evolocumab ‘Abjectly Fails’ Another Financial Stress Test Michael O'Riordan October 19, 2017
News Daily News Lower Limb Revascularizations Increasing in PAD Patients on Dialysis L.A. McKeown October 18, 2017
News Daily News Blood in Urine Carries Consequences for Patients on Antithrombotics Yael L. Maxwell October 09, 2017
News Daily News Same-Day Discharge After PAD Procedures Safe in Elderly Patients L.A. McKeown October 09, 2017
News Daily News CTA Reduces MI Compared With Functional Stress Testing, but at a Cost Michael O'Riordan October 05, 2017
News Daily News Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly Michael O'Riordan September 27, 2017
News Daily News Acute MI Patients With Cancer History Less Likely to Get Evidence-Based Therapies L.A. McKeown September 25, 2017
News Daily News Study Questions Incremental Benefit of Beta-Blockers After Acute MI Michael O'Riordan September 21, 2017
News Daily News Pulmonary Artery Injury More Likely With Real-World Use of CardioMEMS, Analysis Suggests Todd Neale September 19, 2017
News Daily News Frail Patients Benefit From MitraClip, With Gains in Function and Quality of Life Michael O'Riordan September 18, 2017
News Daily News Readmissions After Acute MI Not Only Confined to the Elderly Yael L. Maxwell August 09, 2017
News Daily News Money-Back Guarantee for Evolocumab Has Little Impact on Cost-Effectiveness Michael O'Riordan August 08, 2017